NEW YORK (GenomeWeb News) – Strategic Diagnostics said yesterday that it will provide monoclonal antibodies for a proteomic study being conducted by Science Applications International Corporation – Frederick and the National Cancer Institute.
SDI’s antibodies will be used as reference reagents for the Proteomics Reagents & Resources component of the National Cancer Institute’s Clinical Proteomic Technologies for Cancer initiative.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.